Last reviewed: May 20, 2026

Last updated: May 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Semaglutide significantly reduces appetite and slows gastric emptying, making vitamin and mineral deficiency a real clinical concern. Research shows up to 30% of GLP-1 users develop micronutrient gaps within 6–12 months if supplementation isn't intentional and personalized.

PlexusDx takes a precision-wellness approach: rather than recommending a one-size-fits-all vitamin cocktail, we encourage patients using compounded semaglutide to understand their individual baseline micronutrient status and genetic predispositions to certain deficiencies. This context supports a more informed conversation with your healthcare provider about which supplements truly matter for you.

How Semaglutide Affects Micronutrient Absorption and Status

Semaglutide reduces gastric acid secretion and slows stomach emptying, both of which impair absorption of B12, iron, calcium, and folate. Patients eating 40–50% fewer calories daily face compounded risk of inadequate micronutrient intake even before absorption challenges are considered.

The longer food remains in the stomach, the greater nutrient extraction—but paradoxically, reduced overall food volume means fewer absolute nutrients available. Blood work after 3–6 months on semaglutide often reveals unexpected deficiencies, especially in patients who don't proactively address nutrition.

Priority Micronutrients: Evidence-Based Supplementation Framework

Not all vitamins carry equal clinical urgency. Below is a framework highlighting which micronutrients most commonly decline in semaglutide users and the evidence basis for monitoring or supplementing each one.

Micronutrient Absorption Risk With Semaglutide Typical Deficiency Timeline Provider Monitoring Recommendation
Vitamin B12 High—reduced gastric acid 6–12 months Baseline and 6-month serum B12 or methylmalonic acid
Iron High—lower food intake + acid reduction 3–6 months Ferritin, serum iron, TIBC at baseline and 3 months
Calcium Moderate—acid-dependent absorption 6–12 months Serum calcium and 25-OH vitamin D at baseline
Folate Moderate—reduced intake + absorption 6–12 months Red blood cell folate or serum folate at baseline and 6 months
Vitamin D Moderate—reduced fat intake 3–6 months 25-OH vitamin D at baseline and 6-month recheck

Genetic Predispositions and Individual Micronutrient Risk

Your genes influence how efficiently you absorb B12, how you metabolize folate, and how your body regulates iron homeostasis. Some individuals carry genetic variants that predispose them to faster micronutrient depletion, even without GLP-1 therapy. Semaglutide may amplify these baseline risks.

The PlexusDx Precision Peptide Genetic Test can reveal predispositions in pathways affecting nutrient metabolism and GLP-1 response. This context—combined with baseline micronutrient blood work—may help your provider tailor supplementation strategy rather than guessing which vitamins you actually need.

Practical Supplementation Strategy and Safety Considerations

Start with blood work before beginning compounded semaglutide. Establish your baseline B12, iron panel, calcium, vitamin D, and folate status. This prevents over-supplementing nutrients you don't need while identifying deficiencies that require higher doses or different delivery formats (sublingual B12, intravenous iron, etc.).

Timing matters: separate calcium and iron supplements from each other and from semaglutide dosing by at least 2–4 hours, as they compete for absorption. Take B12 sublingually or via injection if gastric acid is already compromised. Work with your provider to recheck labs every 3–6 months and adjust your regimen based on actual blood values, not assumptions.

How PlexusDx Supports a More Personalized Approach

PlexusDx believes personalized micronutrient strategy should reflect your individual baseline status, genetic predispositions, and the specific demands of compounded semaglutide therapy. Rather than recommend generic multivitamins, we encourage patients to partner with their provider on a data-driven approach. This may help provide context for which supplements deserve your attention and investment.

The Precision Peptide Genetic Test reveals predispositions in nutrient metabolism and absorption pathways relevant to GLP-1 use. Variants in folate metabolism (MTHFR), B12 transport, and iron regulation can influence your individual micronutrient needs. This genetic insight should be interpreted with your qualified healthcare provider and combined with blood work to guide supplementation decisions.

Understanding your genetic context plus your baseline lab values empowers a conversation with your provider about whether you need aggressive B12 replacement, iron supplementation, or higher-dose calcium before deficiency symptoms emerge. This precision-wellness strategy is more efficient and evidence-based than broad supplementation for all semaglutide users.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral starts at $279/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves